Search Within

MSK Grad Students

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (1046)
  2. Meeting Abstract (437)
  3. Review (40)
  4. Research Letter (20)
  5. Editorial (14)
  6. Miscellaneous (10)
  7. Conference Paper (7)
  8. Book Section (5)
  9. Correspondence (1)
Groups
  1. Sloan Kettering Institute Postdocs (1580)
  2. GSK Faculty (1366)
  3. Sloan Kettering Institute Faculty (909)
  4. Department of Medicine (780)
  5. Center for Hematologic Malignancies (525)
  6. Human Oncology and Pathogenesis Program (478)

More Groups

People
  1. Nikolaus Schultz (101)
  2. Christina Leslie (97)
  3. Kevin Soares (95)
  4. William Jarnagin (93)
  5. Michael D'Angelica (87)
  6. T Peter Kingham (86)

More People

Years
  1. 2025 (56)
  2. 2024 (157)
  3. 2023 (174)
  4. 2022 (207)
  5. 2021 (172)
  6. 2020 (237)

More Years

Publications
  1. Blood (133)
  2. Cancer Research (99)
  3. Nature Communications (77)
  4. Nature (71)
  5. Annals of Surgical Oncology (44)
  6. Journal of Clinical Oncology (44)

More Publications

Publishers
  1. Nature Publishing Group (288)
  2. Cell Press (204)
  3. American Association for Cancer Research (188)
  4. American Society of Hematology (141)
  5. Elsevier Inc. (66)
  6. Springer (65)

More Publishers

Results (1580)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Estrogen receptor expression and ER dependent breast tumor growth are dependent on translation initiation factor EIF4A
    Meeting Abstract

    Boyer, J. A.; Dorso, M. A.; Amor, C.; Reiter, J.; Xu, J.; de Stanchina, E.; Wendel, H. G.; Chandarlapaty, S.; Rosen, N.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Development of a patient-derived xenograft (PDX) modeling program to enable pediatric precision medicine
    Meeting Abstract

    Dela Cruz, F. S.; McCarter, J. G.; You, D.; Bouvier, N.; Wang, X.; Guillan, K. C.; Siddiquee, A. H.; Souto, K. B.; Li, H.; Gao, T.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Genomic heterogeneity as a barrier to precision oncology in urothelial cancer
    Meeting Abstract

    Chen, Z.; Clinton, T. N.; Park, S.; Lenis, A. T.; Donoghue, M.; Rosenberg, J. E.; Dean, B. F.; Teo, M. Y.; Bochner, B. H.; Ostrovnaya, I.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert tumor microenvironment
    Meeting Abstract

    Yan, J.; Chen, Y.; Patel, A. J.; Lee, C. J.; Warda, S.; Nixon, B. G.; Wong, E. W. P.; Miranda-Román, M. A.; Yang, N.; Wang, Y.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Molecular subtypes characterize appendiceal adenocarcinoma genomic evolution and disease behavior
    Meeting Abstract

    Foote, M. B.; Walch, H.; Chatila, W.; Vakiani, E.; Chandler, C.; Steinrucke, F.; Nash, G.; Stadler, Z.; Chung, S.; Kemel, Y.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Statin therapy enhances the efficacy of HER2 directed antibody-drug conjugates in breast cancer
    Meeting Abstract

    Liu, B.; Drago, J. Z.; Rao, Y.; Pereira, P. R.; Safonov, A.; Marra, A.; Ahmed, M. S.; Modi, S.; Reis, J. S.; Montemurro, F.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Characterizing SMARCA4/STK11/KEAP1 co-mutant lung adenocarcinoma
    Meeting Abstract

    Costa, E.; Wohlheiter, C.; Tischfield, S.; Funnell, A.; Poirier, J. T.; Villalonga, A. Q.; Sen, T.; Rudin, C.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • STAT3-driven MAPK activation represents a therapeutic vulnerability in ASCL1 high SCLC
    Meeting Abstract

    Caeser, R.; Hulton, C.; Costa, E.; Durani, V.; Little, M.; Chen, X.; Tischfield, S. E.; Asher, M.; Kombak, F. E.; Chavan, S. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Characterization of genomic diversity in high grade serous ovarian and triple negative breast cancer at single cell resolution
    Meeting Abstract

    Williams, M. J.; Funnell, T.; O'Flanagan, C. H.; McPherson, A.; Aparicio, S.; Shah, S. P.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Pharmacologic inhibition of the glycolytic pathway improves response to immune checkpoint blockade
    Meeting Abstract

    Verma, S.; Serganova, I.; Budhu, S.; Dong, L.; Ko, M.; Mangarin, L.; Merghoub, T.; Wolchok, J.; Zappasodi, R.
    Cancer Research (2022)

    Fulltext@MSK | Save